Iowa · G0472

Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Iowa

Iowa Medicare Avg
$45.40
1% above national avg
National Medicare Avg
$44.86
All states combined
Billed Charge (IA)
$62.48
What providers submit
Est. Commercial (IA)
$93.07
National avg: $100.48
Est. Cash / Self-Pay (IA)
$51.23
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

2.0K
Services in IA
110
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Iowa

Provider Medicare Services
Central Iowa Hospital Corporation $45.42 882
Medical Laboratories Of Eastern... $45.42 329
Cunningham, Sean M.D. $45.42 61

Iowa Pricing in Context

In Iowa, CPT code G0472 (Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s)) carries an average Medicare payment of $45.40 — 1% above the national benchmark of $44.86. 110 providers across the state submitted claims for this procedure in 2023, performing 2.0K total services. Individual payments in IA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Iowa is $62.48, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Iowa sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in Iowa lands near $93.07, with self-pay cash prices typically around $51.23. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost in Iowa?

The average Medicare payment for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Iowa is $45.40, which is 1% above the national average of $44.86. Providers in IA typically bill $62.48 for this procedure.

What does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost with insurance in Iowa?

With commercial insurance in Iowa, Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs an estimated $93.07. Without insurance, the estimated cash price is $51.23. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Iowa?

110 providers in Iowa billed Medicare for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in 2023, performing 2.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cheaper in Iowa than the national average?

No — Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs 1% above the national average in Iowa. The state average Medicare payment is $45.40 compared to $44.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial